Immunization with the HBV core 18-27 epitope elicits CTL responses in humans expressing different HLA-A2 supertype molecules

Human Immunology

Volumn 60, Issue 11, 1999, Pages 1013-1017

  Livingston, Brian D ^a   Crimi, Claire ^a   Fikes, John ^a   Chesnut, Robert W ^a   Sidney, John ^a   Sette, Alessandro ^a  

^a Epimmune   (United States)

Author keywords

Cytotoxic T lymphocyte; Epitope; HLA supertypes; Vaccine

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B VACCINE; HLA A2 ANTIGEN;

ARTICLE; CYTOTOXIC T LYMPHOCYTE; HEPATITIS B VIRUS; HLA SYSTEM; HUMAN; IMMUNIZATION; PRIORITY JOURNAL; VIRUS CORE;

ACUTE DISEASE; ALLELES; AMINO ACID SEQUENCE; HEPATITIS B; HEPATITIS B CORE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HLA-A2 ANTIGEN; HUMANS; IMMUNIZATION; IMMUNODOMINANT EPITOPES; IMMUNOLOGIC MEMORY; LIPOPROTEINS; PEPTIDE FRAGMENTS; PROTEIN BINDING; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032752883     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(99)00103-2     Document Type: Article

References (13)

1. Chisari F.V., Ferrari C. Hepatitis B virus immunopathogenesis. Ann Rev Immunol. 13:1995;29.
2. Penna A., Chisari F.V., Bertoletti A., Missale G., Fowler P., Giuberti T., Fiaccadori F., Ferrari C. Cytotoxic T lymphocytes recognize an HLA-A2 restricted epitope within the hepatitis B virus nucleocapsid antigen. J Exp Med. 174:1991;1565.
3. Bertoni R., Sidney J., Fowler P., Chesnut R.W., Chisari F.V., Sette A. Human histocompatibility antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. J Clin Invest. 100:1997;503.
4. Rehermann B., Lau D., Hoofnagle J.H., Chisari F.V. Cytotoxic T lymphocyte responsiveness after resolution of chronic Hepatitis B virus infection. J Clin Invest. 97:1996;1655.
5. Livingston B.D., Crimi C., Grey H., Ishioka G., Chisari F.V., Fikes J., Grey H., Chesnut R.W., Sette A. The Hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection. J Immunol. 159:1997;1383.
6. Livingston B.D., Alexander J., Crimi C., Oseroff C., Celis E., Daly K., Guidotti L.G., Chisari F.V., Fikes J., Chesnut R.W., Sette A. Altered helper T lymphocyte (HTL) function associated with chronic HBV infection and its role in response to therapeutic vaccination in humans. J Immunol. 162:1999;3088.
7. Sette A., Sidney J. HLA supertypes and supermotifs a functional perspective on HLA polymorphism . Curr Opin Immunol. 10:1998;478.
8. Khanna R., Burrows S.R., Nicholls J., Poulsen L.M. Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1) evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes . Eur J Immunol. 28:1998;451.
9. Sette A., Vitiello A., Reherman B., Fowler P., Nayersina R., Kast W.M., Melief C.J.M., Oseroff C., Yaun L., Ruppert J., Sidney J., del Guercio M.-F., Southwood S., Kubo R.T., Chesnut R.W., Grey H.M., Chisari F.V. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J Immunol. 153:1994;5586.
10. Sette A., Sidney J., del Guercio M.-F., Southwood S., Ruppert J., Dahlberg C., Grey H.M., Kubo R.T. Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays. Mol Immunol. 31:1994;813.
11. Bertoletti A., Southwood S., Chesnut R., Sette A., Falco M., Ferrara G.B., Penna A., Boni C., Fiaccadori F., Ferrari C. Molecular features of the hepatitis B virus nucleocapsid T-cell epitope 18-27 Interactions with HLA and T-cell receptor . Hepatology. 26:1997;1027.
12. Barouch D., Friede T., Stevanovic S., Tussey L., Smith K., Rowland-Jones S., Braud V., McMichael A., Rammensee H.-G. HLA-A2 subtypes are functionally distinct in peptide binding and presentation. J Exp Med. 182:1995;1847.
13. Bertoletti A., Sette A., Chisari F.V., Penna A., Levrero M., DeCarli M., Fiaccadori F., Ferrari C. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature. 369:1994;407.